Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture
- PMID: 9003362
- PMCID: PMC1217997
- DOI: 10.1042/bj3200777
Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture
Abstract
We report on the effect of prolonged hyperglycaemic (11 and 30 mM D-glucose) culture conditions on human mesangial cell matrix metalloproteinases (MMPs), plasminogen activators and their inhibitors. The results indicate that hyperglycaemic conditions modulate the potential proteolytic activity of the enzymes secreted by confluent cultures of these cells. Gelatinase A (MMP-2) activity was always higher in cultures maintained under hyperglycaemic than under normoglycaemic conditions (4 mM D-glucose). In contrast, gelatinase B (MMP-9) activity was decreased under the same conditions. Matrilysin (MMP-7) activity was decreased by up to 100% under hyperglycaemic conditions. Reverse transcriptase-PCR and Western-blotting analyses indicate that in all cases both the transcripts and the protein level were correlated with enzymic activity. One tissue inhibitor of metalloproteinases, TIMP-2, was barely detectable under hyperglycaemic conditions (30 mM D-glucose). In contrast, TIMP-1 increased during the initial 2 weeks of culture in hyperglycaemic conditions and remained elevated to the end of the experiment (4 weeks). Under normoglycaemic conditions TIMP-1 decreased after 2 weeks of culture. Hyperglycaemic conditions also decreased markedly the activity of tissue plasminogen activator (t-PA). This seemed to be due to increased synthesis of its inhibitor, plasminogen activator inhibitor 1, under these conditions rather than to decreased expression of the t-PA enzyme.
Similar articles
-
Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.J Cell Physiol. 1996 May;167(2):333-40. doi: 10.1002/(SICI)1097-4652(199605)167:2<333::AID-JCP18>3.0.CO;2-8. J Cell Physiol. 1996. PMID: 8613475
-
Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.Am J Pathol. 1998 Dec;153(6):1895-902. doi: 10.1016/S0002-9440(10)65703-3. Am J Pathol. 1998. PMID: 9846979 Free PMC article.
-
High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1.Exp Nephrol. 2001;9(4):249-57. doi: 10.1159/000052619. Exp Nephrol. 2001. PMID: 11423724
-
Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.Oral Dis. 1996 Mar;2(1):70-6. doi: 10.1111/j.1601-0825.1996.tb00206.x. Oral Dis. 1996. PMID: 8957940 Review.
-
Matrix metalloproteinases and their inhibitors.Anticancer Res. 1999 Mar-Apr;19(2C):1589-92. Anticancer Res. 1999. PMID: 10365151 Review.
Cited by
-
Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.Biochem J. 2001 Oct 1;359(Pt 1):77-87. doi: 10.1042/0264-6021:3590077. Biochem J. 2001. PMID: 11563971 Free PMC article.
-
A mathematical model of glomerular fibrosis in diabetic kidney disease to predict therapeutic efficacy.Front Pharmacol. 2024 Oct 25;15:1481768. doi: 10.3389/fphar.2024.1481768. eCollection 2024. Front Pharmacol. 2024. PMID: 39525640 Free PMC article.
-
Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy.Endocrine. 2009 Feb;35(1):1-10. doi: 10.1007/s12020-008-9114-6. Epub 2008 Oct 30. Endocrine. 2009. PMID: 18972226 Free PMC article. Review.
-
Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.J Endocrinol Invest. 1999 Oct;22(9):708-35. doi: 10.1007/BF03343635. J Endocrinol Invest. 1999. PMID: 10595837 Review. No abstract available.
-
A glimpse of matrix metalloproteinases in diabetic nephropathy.Curr Med Chem. 2014;21(28):3244-60. doi: 10.2174/0929867321666140716092052. Curr Med Chem. 2014. PMID: 25039784 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous